Literature DB >> 20920711

Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.

Mehul V Raval1, Cord Sturgeon, David J Bentrem, Dina M Elaraj, Andrew K Stewart, David J Winchester, Clifford Y Ko, Marleta Reynolds.   

Abstract

PURPOSE: Lymph node metastases (LNM) from medullary thyroid cancer (MTC) are common in adults and are a poor prognostic factor. Less is known about LNM in children, who often have hereditary forms of MTC. Guidelines recommend prophylactic thyroidectomy in early childhood, but randomized prospective trials are not feasible. We hypothesized that LNM is associated with poor prognosis in children.
METHODS: Patients with MTC 21 years or younger from the National Cancer Data Base from 1985 to 2007 were studied. Multivariable logistic regression was used to identify factors associated with lymph node evaluation. Survival was estimated using the Kaplan-Meier method.
RESULTS: Of 430 patients, 276 (64.2%) had nodal evaluation with LNM present in 121 (28.1%). Older patients, those with tumors larger than 2 cm, and those with involved margins were more likely to have LNM (all P < .05). Patients undergoing total thyroidectomy, those with involved margins, and older patients were more likely to undergo lymph node evaluation after controlling for patient, tumor, and hospital factors (all P < .05). Over time an increasing number of patients with MTC have undergone total thyroidectomy. Patients 16 to 21 years of age had lower 10-year overall survival compared to patients 0 to 15 years old (88.7% vs 98.1%, P = .005). Lymph node metastases were also associated with decreased 10-year overall survival (84.4% vs 100%, P < .001).
CONCLUSIONS: In pediatric MTC, LNM predict poorer overall survival. Adequate lymph node assessment can provide valuable prognostic information for the pediatric MTC patient. Lymph node assessment should be considered for older pediatric patients undergoing surgery for hereditary MTC or biopsy confirmed MTC.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20920711     DOI: 10.1016/j.jpedsurg.2010.06.013

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

Review 1.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Authors:  Steven G Waguespack; Thereasa A Rich; Nancy D Perrier; Camilo Jimenez; Gilbert J Cote
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

Review 2.  Hereditary medullary thyroid carcinoma: the management dilemma.

Authors:  Ping Zhou; Jian Liu; Shao-Wen Cheng; Bing Wang; Rong Yang; Ling Peng
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

3.  Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.

Authors:  Lilah F Morris; Steven G Waguespack; Beth S Edeiken-Monroe; Jeff E Lee; Thereasa A Rich; Anita K Ying; Carla L Warneke; Douglas B Evans; Nancy D Perrier; Elizabeth G Grubbs
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

4.  Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

Authors:  Bruno Niederle; Frédéric Sebag; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-12-03       Impact factor: 3.445

5.  Lymph node metastases in pediatric medullary thyroid carcinoma.

Authors:  Jamie R Oliver; Kepal N Patel; Clifford M Chang; Chelsey K Baldwin; Preneet C Brar; Luc G T Morris; Babak Givi
Journal:  Surgery       Date:  2021-04-08       Impact factor: 4.348

6.  Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy.

Authors:  Maya Lodish; Alexandra Gkourogianni; Ethan Bornstein; Ninet Sinaii; Elizabeth Fox; Meredith Chuk; Leigh Marcus; Srivandana Akshintala; Frank Balis; Brigitte Widemann; Constantine A Stratakis
Journal:  Int J Pediatr Endocrinol       Date:  2015-02-16

7.  Pediatric Medullary Thyroid Carcinoma.

Authors:  Dmytro Starenki; Jong-In Park
Journal:  J Pediatr Oncol       Date:  2015

8.  Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program.

Authors:  Zhuang Zhao; Xiang-Dang Yin; Xu-He Zhang; Zhi-Wen Li; Dun-Wei Wang
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.